These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1366929

  • 1. Gene replacement in Bordetella pertussis by transformation with linear DNA.
    Zealey GR, Loosmore SM, Yacoob RK, Cockle SA, Boux LJ, Miller LD, Klein MH.
    Biotechnology (N Y); 1990 Nov; 8(11):1025-9. PubMed ID: 1366929
    [Abstract] [Full Text] [Related]

  • 2. Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin.
    Zealey GR, Loosmore SM, Yacoob RK, Cockle SA, Herbert AB, Miller LD, Mackay NJ, Klein MH.
    Appl Environ Microbiol; 1992 Jan; 58(1):208-14. PubMed ID: 1539974
    [Abstract] [Full Text] [Related]

  • 3. Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.
    Loosmore SM, Zealey GR, Boux HA, Cockle SA, Radika K, Fahim RE, Zobrist GJ, Yacoob RK, Chong PC, Yao FL.
    Infect Immun; 1990 Nov; 58(11):3653-62. PubMed ID: 2228237
    [Abstract] [Full Text] [Related]

  • 4. Stable expression of pertussis toxin in Bordetella bronchiseptica under the control of a tightly regulated promoter.
    Suarez A, Staendner LH, Rohde M, Piatti G, Timmis KN, Guzmán CA.
    Appl Environ Microbiol; 1997 Jan; 63(1):122-7. PubMed ID: 8979346
    [Abstract] [Full Text] [Related]

  • 5. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y, Sato H, Chazono M, Ginnaga A, Tamura C.
    Dev Biol Stand; 1991 Jan; 73():93-107. PubMed ID: 1778339
    [Abstract] [Full Text] [Related]

  • 6. Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica.
    Walker MJ, Rohde M, Wehland J, Timmis KN.
    Infect Immun; 1991 Nov; 59(11):4238-48. PubMed ID: 1682257
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Construction of the genetically attenuated bacteria Bordetella pertussis devoid of dermonecrotic toxin activity and producing modified nontoxic pertussis toxin form].
    Siniashina LN, Siniashina LS, Semin EG, Amelina IP, Karataev GI.
    Mol Gen Mikrobiol Virusol; 2010 Nov; (3):31-6. PubMed ID: 20886687
    [Abstract] [Full Text] [Related]

  • 10. Engineering bacterial toxin for the development of new vaccine against pertussis.
    Bartoloni A, Pizza M, Gross R, Perugini M, Arico B, Domenighini M, Rappuoli R.
    Tokai J Exp Clin Med; 1988 Nov; 13 Suppl():217-22. PubMed ID: 2483870
    [Abstract] [Full Text] [Related]

  • 11. [Cellular and acellular anti-pertussis vaccines].
    Locht C.
    Ann Pharm Fr; 2001 May; 59(3):198-205. PubMed ID: 11427821
    [Abstract] [Full Text] [Related]

  • 12. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D, Gaillard ME, Fingermann M, Weltman G, Fernández J, Sisti F, Graieb A, Roberts R, Rico O, Ríos G, Regueira M, Binsztein N, Hozbor D.
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Promoter of the pertussis toxin operon and production of pertussis toxin.
    Nicosia A, Rappuoli R.
    J Bacteriol; 1987 Jun; 169(6):2843-6. PubMed ID: 2438270
    [Abstract] [Full Text] [Related]

  • 16. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland.
    Gzyl A, Augustynowicz E, van Loo I, Slusarczyk J.
    Vaccine; 2001 Nov 12; 20(3-4):299-303. PubMed ID: 11672891
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Progress towards the development of new vaccines against whooping cough.
    Rappuoli R, Podda A, Pizza M, Covacci A, Bartoloni A, de Magistris MT, Nencioni L.
    Vaccine; 1992 Nov 12; 10(14):1027-32. PubMed ID: 1471424
    [Abstract] [Full Text] [Related]

  • 20. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N, Guiso N.
    Expert Rev Vaccines; 2014 Sep 12; 13(9):1135-46. PubMed ID: 24953157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.